La cadena de opciones muestra datos clave de las opciones de acciones de Asana a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Asana..

Asana (NYSE:ASAN) Bolsa, Cadena de Opciones

Asana

Asana is a provider of collaborative work management software delivered via a cloud-based SaaS model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases, including marketing programs, managing IT approvals, and performance management. Asana's offering supports workflow management across teams, provides real time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per seat basis.

ASAN

DLTR

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este miércoles: DLTR, PD, DKS, ASAN y HPE.

5 acciones en el foco este miércoles: DLTR, PD, DKS, ASAN y HPE

Asana Inc

ASANTE Inc

Asante Gold Corp

Asanuma Corp

Scotiabank analyst Cameron Bean maintains Topaz Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TPZ#TSX">TPZ</a>) with a Sector Outperform and raises the price target from C$34 to C$35.

News

Price Target

Analyst Ratings

TSX:TPZ

Scotiabank Maintains Sector Outperform on Topaz Energy, Raises Price Target to C$35

BTIG analyst Gray Powell maintains Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) with a Buy and raises the price target from $57 to $63.

BTIG Maintains Buy on Dynatrace, Raises Price Target to $63

McDonald&#39;s Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mcd#NYSE">MCD</a>)&nbsp;has gained 24.2% in the past three months, outperforming the Zacks <a href="https://www.zacks.com/stocks/industry-rank/industry/retail-restaurants-160">Retail - Restaurants</a> industry, the Zacks <a href="https://www.zacks.com/stocks/industry-rank/sector/retail-wholesale-3">Retail-Wholesale</a> sector and the S&amp;P 500 Index, which rose 20.4%, 10.7% and 7.4%, respectively.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/06/82254.jpg?v=663129858" style="height:292px; width:624px" /> 
Image Source: Zacks Investment Research
The company is benefiting from its focus on enhancing customer experiences through its 4D Growth strategy and increased global franchise units. This, alongside an effective capital allocation strategy, has added to the uptrend, given its focus on maintaining shareholder value. 
MCD stock has also outperformed some major industry players, including Yum! Brands, Inc. YUM, Domino&#39;s Pizza, Inc. DPZ and Wingstop Inc. WING, in the past three months. In the said time frame, YUM and DPZ have rallied 5.9% and 0.5%, respectively, while WING has lost 1.2%.
<h3>Factors Driving MCD Stock</h3>
4D Growth Pillar: McDonald&#39;s continues unraveling new and improved ways to enhance customer experiences and drive growth. One of the company&#39;s primary tools to offer customers a more personalized and convenient experience is the 4D Growth Pillar, wherein 4D stands for Digital, Delivery, Drive Thru and Development. The Digital aspect encompasses the company&#39;s top-tier loyalty program available on its digital platform, which now has more than 150 million 90-day active users in approximately 50 markets globally.&nbsp; It anticipates 90-day active users to reach 250 million and annual loyalty system-wide sales to reach $45 billion by 2027. 
Regarding the Delivery and Drive Thru aspects, the company offers delivery services through McDelivery or third-party delivery providers in about 100 global markets, which represent more than 85% of its restaurants. Considering drive-thrus under the delivery section, the company houses quite a number of drive-thru locations across the globe, with more than 27,000 drive-thru locations globally. With the increase in delivery sales mix over the past few years, mainly in Australia, Canada and the United States, and leveraging its long-term strategic partnerships with delivery providers, the company aims to offer seamless customer experiences. 
Considering the Development aspect, McDonald&#39;s is banking on increased demand patterns globally and increasing its foothold by boosting its presence in existing markets and by entering new ones. The company is planning to open more than 2,100 new restaurants globally in 2024, including 500 openings in the United States and International Operated Markets (IOM) segment and 1,600 (including nearly 1000 in China) inaugurations in the International Developmental Licensed (IDL) market. Furthermore, it aims to open 50,000 restaurants by 2027. 
Franchised Revenues Offer Stability: Among the total restaurants worldwide of McDonald&#39;s, 95% were franchised restaurants as of June 30, 2024. The company operates in three reportable segments, wherein the U.S. segment has about 95% franchised ownership mix, the IOM segment has 89% franchised ownership mix and the IDL segment has 98% franchised ownership mix. 
This asset-light business strategy, having more franchised store units across the world, makes its operations less susceptible to market volatility than the company running its outlets on its own. The diversity in market conditions and regulatory hurdles across different nations would make it difficult for MCD to handle operations. This business strategy will offer it higher profit margins and a stable source of revenues. During the first six months of 2024, about 60.5% of revenues came from franchised restaurants. 
Effective Capital Allocation Strategy: The company follows an effective capital allocation strategy, wherein it aims to utilize its free cash flow in new business opportunities, dividend payouts and share repurchases. MCD&#39;s way of prioritizing shareholder value apart from business investments is encouraging in the industry. 
Maintaining its history of increasing dividend payments for 47 consecutive years, McDonald&#39;s has again announced a hike in its quarterly cash dividend on Sept. 25, 2024. It raised its quarterly dividend by 6% to $1.77 per share ($7.08 per share annually) from $1.67 per share ($6.68 per share annually). The dividend is to be paid on Dec. 16, 2024 to shareholders as of Dec. 2.
<h3>Estimate Trend Favors McDonald&#39;s</h3>
The Zacks Consensus Estimate for MCD&#39;s third-quarter and 2024 earnings per share (ETF:EPS) has trended upward in the past seven days. The uptrend can be witnessed from the chart given below.
EPS Trend
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/d9/82252.jpg?v=159574847" /> 
Image Source: Zacks Investment Research
<h2>MCD Trading Above 50 &amp; 200-Day SMA</h2>
Technical indicators suggest a continued strong performance for McDonald&#39;s. From the graphical representation given below, it can be observed that MCD stock is trading above both the 50-day simple moving average (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sma#NYSE">SMA</a>) and 200-day SMA, signaling a bullish trend. The technical strength underscores positive market sentiment and confidence in MCD&#39;s financial health and prospects.
50 &amp; 200-Day Moving Average
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/32/82255.jpg?v=162340666" /> 
Image Source: Zacks Investment Research
<h2>MCD Trading at a Discount</h2>
McDonald&#39;s is currently trading at a discount compared with the industry peers on a forward 12-month price-to-earnings (P/E) ratio basis. The discounted valuation indicates that despite the recent stock price increase in the past three months, it remains an attractive option for investors looking for a suitable entry point.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c5/82253.jpg?v=1631045805" /> 
Image Source: Zacks Investment Research
<h2>Hurdles to MCD&#39;s Momentum</h2>
The tailwinds discussed above is helping McDonald&#39;s to move through the ongoing macro challenges and inflationary risks. However, headwinds like soft comparable store sales and high costs and expenses are pulling back the growth prospects to some extent. 
Soft Comps: McDonald&#39;s is facing challenges regarding weaker comparable store sales growth. The company&#39;s comps are hurt mainly due to negative comparable guest counts witnessed in the U.S. market and negative comparable sales in France witnessed under the IOM segment. The international market&#39;s trends are unfavorable since customers are wary of discretionary spending given the ongoing market challenges. 
Under the IDL segment, the continued impact of the war in the Middle East and negative comparable sales in China have resulted in declining comps. For the first six months of 2024, comparable sales under this segment decreased 0.8%. 
High Cost &amp; Expenses: The persisting inflationary pressures are hurting the company&#39;s margins. During the first six months of 2024, the company&#39;s total operating costs and expenses escalated 4% year over year to $7 billion due to increased restaurant and occupancy expenses along with selling, general and administrative expenses. 
The company anticipates operating margin to remain pressurized in the near term with labor inflation expected to be in the high single digits in 2024.
<h2>Is it a Wise Decision to Add MCD to Your Portfolio Now?</h2>
As discussed above, despite the ongoing macro hurdles and inflationary risks, McDonald&#39;s is gaining momentum in this competitive industry through its top-tier business strategies. The core business strategies of the company highlight its aim of delivering enhanced and personalized customer experiences, making strategic investments in growth opportunities and maintaining a consistent shareholder value. 
With the goals set through 2027 and the recent take on the dividend hike, along with increased franchised units, the company seems to be well-positioned to move through the uncertainties and deliver an outperformance in the upcoming period. 
Thus, based on the overall discussion and the trends of technical indicators, it is suggested to the existing investors to hold on to this Zacks Rank #3 (Hold) company&#39;s shares for now, whereas new investors might want to wait for a more favorable entry point given high costs and weaker comparable store sales growth.
<a href="https://www.zacks.com/stock/news/2356040/mcdonald-s-stock-jumps-24-in-3-months-should-you-buy-sell-or-hold?cid=CS-BENZ-FT-analyst_blog|most_popular_stocks-2356040">To read this article on Zacks.com click here.</a>

Restaurants

Trading Ideas

General

WING

McDonald's Stock Jumps 24% In 3 Months: Should You Buy, Sell Or Hold?

WIIM

OKYO

OKYO Pharma shares are trading higher after the company announced it dosed its first patient in a clinical trial to meet Neuropathic Corneal pain.

Scotiabank analyst Orest Wowkodaw maintains Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) with a Sector Perform and lowers the price target from $53 to $52.

Scotiabank Maintains Sector Perform on Freeport-McMoRan, Lowers Price Target to $52

With less than two weeks to the <a href="https://www.benzinga.com/topic/election-day">ballot vote</a>, the debate around Florida's<a href="https://www.benzinga.com/markets/cannabis/24/10/41405555/floridas-cannabis-amendment-record-spending-unlikely-alliances-and-criticism-from-the-catholic-c"> Amendment 3 </a>is heating up. Trulieve Cannabis Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) CEO Kim Rivers came out swinging in an appearance on a WESH2 <a href="https://www.wesh.com/article/trulieve-ceo-anti-amendment-3-recreational-cannabis-ads-distortions/62684977">news report</a> in which she described the anti-cannabis ads running throughout the state as &#8220;distortions.&#8221;
Rivers has taken issue with the portrayal of Amendment 3 in <a href="https://www.benzinga.com/markets/cannabis/24/10/41405555/floridas-cannabis-amendment-record-spending-unlikely-alliances-and-criticism-from-the-catholic-c">political ads</a> that claim the measure would create a cannabis monopoly in the state. 
&#8220;The economic door to prosperity would be open to many,&#8221; Rivers stated, dismissing the suggestion that the amendment would only benefit large corporations like Trulieve. 
The initiative, she argues, is about broadening opportunities in an industry projected for <a href="https://www.benzinga.com/markets/cannabis/24/10/41335229/cannabis-industrys-130b-growth-potential-top-states-for-investment-as-financial-institutions-set">explosive growth</a>.
During a recent visit to one of Trulieve's 155 <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/markets/cannabis/24/07/39871979/floridas-medical-cannabis-market-sees-explosive-growth-ahead-of-november-legalization-ballot&amp;ved=2ahUKEwimgou_-qSJAxWrrJUCHULWIkgQFnoECBkQAQ&amp;usg=AOvVaw0aYsig6m9Yhjuv_bk1bdHr">dispensaries</a>, Rivers spoke to employees about the significance of the amendment, which would legalize recreational cannabis for adults over 21.
<h3 class="wp-block-heading">Addressing Child Safety Concerns</h3>
One of the central points of contention in the opposition's campaign is the claim that legalizing cannabis will expose children to products packaged to resemble candy. Rivers has been vocal in rebutting these assertions.
 &#8220;These are adult products, packaged for adults, sold to adults,&#8221; she said. 
Rivers explained that recreational cannabis, like medical marijuana, would adhere to strict packaging guidelines designed to prevent any appeal to children.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can't afford to miss out if you&#8217;re serious about the business.</li>
</ul>
Her point was reinforced by Trulieve Medical Director Dr. Terel Newton, who added, &#8220;You won't see bright colors, animals, or neon packaging that would attract kids.&#8221;
According to Rivers, these types of regulations would continue under an adult-use program, ensuring that products are marketed responsibly.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41365515/ron-desantis-pregnant-pigs-and-floridas-cannabis-legalization-battle-over-constitutional-amendme">Ron DeSantis, Pregnant Pigs And Florida&#8217;s Cannabis Legalization: Battle Over Constitutional Amendment Rages</a>
<h3 class="wp-block-heading">Fear Vs Facts</h3>
For Rivers, the campaign against Amendment 3 is built on fear rather than facts.
&#8220;And I would fully expect and anticipate that those laws and those restrictions will continue in the state of Florida with the adult use program,&#8221; she told the WESH reporter. I think it is really critical for folks to understand what this is and what this is not.&#8221; 
The fight against misleading ads and scary tactics in Florida had another <a href="https://www.benzinga.com/markets/cannabis/24/10/41411270/desantis-doubles-down-with-new-taxpayer-funded-anti-marijuana-ads-one-links-cannabis-to-domestic">recent episode</a> when Gov. Ron DeSantis leveraged the Florida Department of Education to fund a new ad campaign warning against cannabis. 
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/10/41303141/fact-check-desantis-why-floridas-weed-legalization-does-not-mean-smoking-in-schools">Fact-Check DeSantis: Why Florida&#8217;s Weed Legalization Does Not Mean Smoking In Schools</a></li>
</ul>
Cover: Photo by <a href="https://pixabay.com/es/users/jessica45-2055892/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=1409763">jessica45</a> in <a href="https://pixabay.com/es//?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=1409763">Pixabay</a>

Cannabis

Politics

Legal

Markets

TCNNF

Trulieve CEO Kim Rivers Calls Out 'Distortions' In Ads Opposing Florida's Cannabis Amendment

Scotiabank analyst Mario Saric maintains ALLIED PROPS REAL ESTATE INV TST (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AP#TSX">AP</a>) with a Sector Outperform and raises the price target from C$21 to C$22.

TSX:AP

Scotiabank Maintains Sector Outperform on ALLIED PROPS REAL ESTATE INV TST, Raises Price Target to C$22

<a href="https://x.com/mingchikuo/status/1849144029423997038" title="https://x.com/mingchikuo/status/1849144029423997038">https://x.com/mingchikuo/status/1849144029423997038</a>

TSLA

Analyst Ming-Chi Kuo Post On X, "Tesla survey and prediction updates: 1. The more affordable new model (dubbed "Model 2" by some) is unlikely to enter mass production until 2H25 at the earliest. 2. The Model Y refresh is expected to start mass production in 1Q25."

Apple Inc. is nearing production of updated MacBook Airs with M4 chips for release in early 2025, a follow-up to a wave of new Macs that are coming next week, according to people familiar with the matter.&nbsp;
<a href="https://www.bloomberg.com/news/articles/2024-10-23/apple-makes-headway-on-m4-macbook-air-and-plans-new-low-end-ipad?srnd=phx-technology&amp;embedded-checkout=true" title="https://www.bloomberg.com/news/articles/2024-10-23/apple-makes-headway-on-m4-macbook-air-and-plans-new-low-end-ipad?srnd=phx-technology&amp;embedded-checkout=true">https://www.bloomberg.com/news/articles/2024-10-23/apple-makes-headway-on-m4-macbook-air-and-plans-new-low-end-ipad?srnd=phx-technology&amp;embedded-checkout=true</a>

AAPL

'Apple Makes Headway on M4 MacBook Air and Plans New Low-End iPad' - Bloomberg

JP Morgan analyst Mark Murphy maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Overweight and lowers the price target from $19 to $17.

PATH

JP Morgan Maintains Overweight on UiPath, Lowers Price Target to $17

JP Morgan analyst Brian Ossenbeck maintains TFI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFII#NYSE">TFII</a>) with a Overweight and lowers the price target from $181 to $178.

TFII

JP Morgan Maintains Overweight on TFI International, Lowers Price Target to $178

Analysts are weighing in after Starbucks Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) on Tuesday reported worse-than-expected preliminary fourth-quarter results and suspended <a href="https://www.benzinga.com/trading-ideas/technicals/24/10/41493540/stock-of-the-day-starbucks-finds-support-at-94-will-a-bidding-war-force-stock-into-an-up">its guidance for 2025.&nbsp;</a>
The Details: In a surprise move, Starbucks reported <a href="https://www.benzinga.com/news/earnings/24/10/41468529/starbucks-stock-stumbles-after-company-reports-weak-preliminary-results-suspends-guidance">preliminary results</a> for the fourth quarter showing that it expects consolidated net revenues to decline 3% and global comparable sales to fall 7%. Starbucks also said it anticipates earnings of 80 cents per share, down 25% year-over-year.&nbsp;
KeyBanc Captial Markets analyst Eric Gonzalez said that though investors had braced for disappointing fourth-quarter results from Starbucks, they may not have been prepared for the "magnitude of the top- and bottom-line miss." 
Gonzalez did express confidence in the leadership of new CEO Brian Niccol and pointed to his successful tenure as CEO at Chipotle Mexican Grill.&nbsp;
BofA Securities analyst Sara Senatore also highlighted Niccol's successful turnaround of Chipotle and see him as "well-suited" for a Starbucks turnaround. BofA Securities reiterated its Buy rating and $117 price target and said the Starbucks brand "remains fundamentally strong."
Read Next: <a href="https://www.benzinga.com/news/24/10/41418987/nuclear-energy-stocks-are-hot-heres-a-list-of-tickers-to-watch">Nuclear Energy Stocks Are Hot: Here&#8217;s A List Of Tickers To Watch</a>
Stifel analyst Chris O'Cull echoed similar sentiments regarding the abilities of Niccol as CEO and said he is "zeroing in on the correct issues" in his "Back To Starbucks" strategy. Stifel maintained its Buy rating but lowered its price target from $110 to $105.&nbsp;
Looking ahead, Goldman Sachs analysts said they will be watching for more details on the "Back to Starbucks" plan in the company's earnings call on Oct. 30 after the closing bell. Goldman Sachs specifically will listen for more details on the company's pricing strategy, key marketing message and required store-level investments needed to address staffing issues and removing bottlenecks. 
Goldman Sachs analyst Christine Cho maintained Starbucks with a Buy rating and lowered the price target from $110 to $105.
Other analysts updated coverage on Starbucks as well:&nbsp;
<ul>
<li>TD Cowen analyst Andrew Charles reiterated a Buy rating and $110 price target.</li>
<li>UBS analyst Dennis Geiger maintained a Neutral rating but raised the price target from $85 to $95.</li>
</ul>
Starbucks will report its fourth-quarter results after the market close on Oct. 30, followed by a conference call at 5 p.m. ET.
SBUX Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Starbucks shares are down 0.64% at $96.21 at the time of publication Wednesday.
Read Also:&nbsp;
<ul>
<li>&nbsp;<a href="https://www.benzinga.com/news/24/10/41415824/lucid-ceo-peter-rawlinson-talks-saudi-investment-elon-musks-political-views-and-taking-business-from">Lucid CEO Peter Rawlinson Talks Saudi Investment, Elon Musk&#8217;s Political Views And Taking Business From Tesla</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Earnings

Guidance

Movers

SBUX

Starbucks Analysts Bullish On CEO Brian Niccol After Tough Preannouncement: 'Zeroing In' On Right Issues

JP Morgan analyst Andrew Steinerman maintains Robert Half (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHI#NYSE">RHI</a>) with a Neutral and lowers the price target from $70 to $69.

JP Morgan Maintains Neutral on Robert Half, Lowers Price Target to $69

On Tuesday, Alto Neuroscience, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANRO#NYSE">ANRO</a>) revealed that the Phase 2b study of ALTO-100 for major depressive disorder (MDD) did not meet its primary endpoint <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41466981/alto-neuroscience-reports-topline-results-from-a-phase-2b-trial-evaluating-alto-100-as-a-treatment" rel="noreferrer noopener">compared to placebo</a>.
The biomarker-defined major depressive disorder patient group treated with ALTO-100 did not demonstrate a statistically significant improvement in depressive symptoms compared to placebo.
ALTO-100 did not demonstrate a benefit over the placebo on the pre-specified key secondary analyses.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38388220/treatment-patch-for-schizophrenia-newly-listed-alto-neuroscience-is-uniquely-positi" rel="noreferrer noopener">Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In Neuropsychiatry Landscape</a>.
ALTO-100 continued to demonstrate a favorable safety and tolerability profile, with no new safety signals observed in this study compared to the previously completed clinical trials of ALTO-100.
<ul>
<li>The most common adverse events from the trial related to treatment with ALTO-100 were headache, nausea, and abnormal dreams – all of which were experienced at similar rates to placebo.</li>
</ul>
The company expects to complete an analysis of the full data set to determine the most appropriate next steps, if any, to further evaluate ALTO-100 in major depressive disorder.
ALTO-100 is also being evaluated as an adjunctive treatment in a Phase 2b study for bipolar depression.
The company expects its <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40350770/alto-neuroscience-reports-second-quarter-2024-financial-results-and-recent-business-highlights" rel="noreferrer noopener">current cash position</a> of $194 million to fund planned operations into 2027 and through multiple upcoming clinical readouts, including two additional readouts in major depressive disorder, with ALTO-203 and ALTO-300 expected in the first half of 2025.
William Blair notes that despite the setback with ALTO-100, which may raise concerns among investors about Alto&#8217;s Precision Psychiatry Platform, the analysts do not consider this single failure to undermine the validity of their biomarker enrichment strategy.
The analyst is now focused on the upcoming ALTO-300 Phase 2b results in major depressive disorder (MDD), anticipated in the first half of 2025, for further insights.
&#8220;While data points draw increased scrutiny on the biomarker stratification approach, historically placebo-controlled MDD studies have been high-risk, and this one appears no different. Still, in our discussions with management, it remained confident in the stratification approach, and we will await a fuller dataset to better understand this optimism despite the negative Phase 2b readout.&#8221; William Blair analysts write.
The analyst maintains <a target="_blank" href="https://www.benzinga.com/quote/ANRO/analyst-ratings" rel="noreferrer noopener">the Outperform rating</a>.
Price Action: At last check on Wednesday, ANRO stock was down 67.70% to $4.70.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41486650/coca-cola-q3-earnings-eps-beat-pricing-growth-offset-by-volume-decline-sees-10-q4-organic-revenue-g" target="_blank" rel="noreferrer noopener">Coca-Cola Q3 Earnings: EPS Beat, Pricing Growth Offset By Volume Decline, Sees 10% Q4 Organic Revenue Growth</a>.</li>
</ul>

Biotech

Health Care

ANRO

Neuropsychiatry-Focused Alto Neuroscience's Mid-Stage Depression Trial Disappoints, Analyst Notes Failure Raises Concerns About Platform

- Reuters Citing Spokesperson&nbsp;

Hershey Company Has Banned Use Of PFAS Chemicals Globally For Well Over A Decade

JP Morgan analyst Bill Peterson maintains Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) with a Overweight and lowers the price target from $170 to $168.

JP Morgan Maintains Overweight on Nucor, Lowers Price Target to $168

B of A Securities analyst Vivek Arya maintains Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) with a Neutral and lowers the price target from $220 to $215.

B of A Securities Maintains Neutral on Texas Instruments, Lowers Price Target to $215

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>COIN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/25/24</td>
<td>$190.00</td>
<td>$42.2K</td>
<td>3.3K</td>
<td>6.9K</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$490.00</td>
<td>$49.3K</td>
<td>259</td>
<td>1.0K</td>
</tr>
<tr>
<td>YRD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$5.00</td>
<td>$47.7K</td>
<td>893</td>
<td>555</td>
</tr>
<tr>
<td>LC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$12.00</td>
<td>$31.0K</td>
<td>9</td>
<td>198</td>
</tr>
<tr>
<td>STWD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$20.00</td>
<td>$38.2K</td>
<td>1.2K</td>
<td>150</td>
</tr>
<tr>
<td>SCHW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$77.50</td>
<td>$26.1K</td>
<td>96</td>
<td>138</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$230.00</td>
<td>$47.1K</td>
<td>1.0K</td>
<td>115</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$27.00</td>
<td>$60.1K</td>
<td>0</td>
<td>101</td>
</tr>
<tr>
<td>ERIE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$410.00</td>
<td>$30.4K</td>
<td>2</td>
<td>40</td>
</tr>
<tr>
<td>GPN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$110.00</td>
<td>$41.7K</td>
<td>11</td>
<td>26</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we notice a put option trade that happens to be bearish, expiring in 2 day(s) on October 25, 2024. This event was a transfer of 200 contract(s) at a $190.00 strike. The total cost received by the writing party (or parties) was $42.2K, with a price of $211.0 per contract. There were 3391 open contracts at this strike prior to today, and today 6927 contract(s) were bought and sold. 
• Regarding GS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), we observe a put option sweep with bearish sentiment. It expires in 149 day(s) on March 21, 2025. Parties traded 25 contract(s) at a $490.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $49.3K, with a price of $1975.0 per contract. There were 259 open contracts at this strike prior to today, and today 1004 contract(s) were bought and sold. 
• Regarding YRD (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>), we observe a call option sweep with bearish sentiment. It expires in 23 day(s) on November 15, 2024. Parties traded 455 contract(s) at a $5.00 strike. This particular call needed to be split into 34 different trades to become filled. The total cost received by the writing party (or parties) was $47.7K, with a price of $105.0 per contract. There were 893 open contracts at this strike prior to today, and today 555 contract(s) were bought and sold. 
• For LC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>), we notice a call option sweep that happens to be bullish, expiring in 58 day(s) on December 20, 2024. This event was a transfer of 188 contract(s) at a $12.00 strike. This particular call needed to be split into 23 different trades to become filled. The total cost received by the writing party (or parties) was $31.0K, with a price of $165.0 per contract. There were 9 open contracts at this strike prior to today, and today 198 contract(s) were bought and sold. 
• For STWD (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STWD#NYSE">STWD</a>), we notice a put option sweep that happens to be bullish, expiring in 450 day(s) on January 16, 2026. This event was a transfer of 150 contract(s) at a $20.00 strike. This particular put needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $38.2K, with a price of $255.0 per contract. There were 1221 open contracts at this strike prior to today, and today 150 contract(s) were bought and sold. 
• Regarding SCHW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>), we observe a call option trade with bullish sentiment. It expires in 331 day(s) on September 19, 2025. Parties traded 48 contract(s) at a $77.50 strike. The total cost received by the writing party (or parties) was $26.1K, with a price of $545.0 per contract. There were 96 open contracts at this strike prior to today, and today 138 contract(s) were bought and sold. 
• Regarding JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we observe a call option trade with bearish sentiment. It expires in 121 day(s) on February 21, 2025. Parties traded 50 contract(s) at a $230.00 strike. The total cost received by the writing party (or parties) was $47.1K, with a price of $943.0 per contract. There were 1081 open contracts at this strike prior to today, and today 115 contract(s) were bought and sold. 
• Regarding HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we observe a call option sweep with bullish sentiment. It expires in 296 day(s) on August 15, 2025. Parties traded 101 contract(s) at a $27.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $60.1K, with a price of $595.0 per contract. There were 0 open contracts at this strike prior to today, and today 101 contract(s) were bought and sold. 
• Regarding ERIE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIE#NASDAQ">ERIE</a>), we observe a put option trade with bullish sentiment. It expires in 58 day(s) on December 20, 2024. Parties traded 40 contract(s) at a $410.00 strike. The total cost received by the writing party (or parties) was $30.4K, with a price of $760.0 per contract. There were 2 open contracts at this strike prior to today, and today 40 contract(s) were bought and sold. 
• Regarding GPN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>), we observe a put option trade with bearish sentiment. It expires in 331 day(s) on September 19, 2025. Parties traded 25 contract(s) at a $110.00 strike. The total cost received by the writing party (or parties) was $41.7K, with a price of $1670.0 per contract. There were 11 open contracts at this strike prior to today, and today 26 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

COIN

ERIE

HOOD

SCHW

STWD

10 Financials Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/25/24</td>
<td>$215.00</td>
<td>$59.2K</td>
<td>12.6K</td>
<td>24.3K</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/25/24</td>
<td>$100.00</td>
<td>$27.9K</td>
<td>3.8K</td>
<td>4.8K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$180.00</td>
<td>$97.8K</td>
<td>7.4K</td>
<td>1.2K</td>
</tr>
<tr>
<td>CZR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$50.00</td>
<td>$50.1K</td>
<td>17.3K</td>
<td>795</td>
</tr>
<tr>
<td>HD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$440.00</td>
<td>$76.5K</td>
<td>18</td>
<td>625</td>
</tr>
<tr>
<td>TJX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$120.00</td>
<td>$52.9K</td>
<td>1.0K</td>
<td>402</td>
</tr>
<tr>
<td>GM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/01/24</td>
<td>$50.00</td>
<td>$34.1K</td>
<td>7.4K</td>
<td>310</td>
</tr>
<tr>
<td>GCT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$25.00</td>
<td>$28.1K</td>
<td>4.8K</td>
<td>237</td>
</tr>
<tr>
<td>BLD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$370.00</td>
<td>$50.4K</td>
<td>10</td>
<td>237</td>
</tr>
<tr>
<td>WGO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$60.00</td>
<td>$26.7K</td>
<td>2.3K</td>
<td>211</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a put option trade that happens to be neutral, expiring in 2 day(s) on October 25, 2024. This event was a transfer of 67 contract(s) at a $215.00 strike. The total cost received by the writing party (or parties) was $59.2K, with a price of $885.0 per contract. There were 12624 open contracts at this strike prior to today, and today 24399 contract(s) were bought and sold. 
• Regarding BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on October 25, 2024. Parties traded 500 contract(s) at a $100.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $27.9K, with a price of $56.0 per contract. There were 3843 open contracts at this strike prior to today, and today 4882 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a call option trade with bearish sentiment. It expires in 240 day(s) on June 20, 2025. Parties traded 40 contract(s) at a $180.00 strike. The total cost received by the writing party (or parties) was $97.8K, with a price of $2445.0 per contract. There were 7475 open contracts at this strike prior to today, and today 1266 contract(s) were bought and sold. 
• For CZR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>), we notice a call option sweep that happens to be bearish, expiring in 450 day(s) on January 16, 2026. This event was a transfer of 76 contract(s) at a $50.00 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $50.1K, with a price of $660.0 per contract. There were 17322 open contracts at this strike prior to today, and today 795 contract(s) were bought and sold. 
• For HD (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>), we notice a call option sweep that happens to be bullish, expiring in 37 day(s) on November 29, 2024. This event was a transfer of 603 contract(s) at a $440.00 strike. This particular call needed to be split into 75 different trades to become filled. The total cost received by the writing party (or parties) was $76.5K, with a price of $127.0 per contract. There were 18 open contracts at this strike prior to today, and today 625 contract(s) were bought and sold. 
• Regarding TJX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>), we observe a call option sweep with bullish sentiment. It expires in 240 day(s) on June 20, 2025. Parties traded 79 contract(s) at a $120.00 strike. This particular call needed to be split into 23 different trades to become filled. The total cost received by the writing party (or parties) was $52.9K, with a price of $670.0 per contract. There were 1071 open contracts at this strike prior to today, and today 402 contract(s) were bought and sold. 
• Regarding GM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), we observe a call option sweep with bearish sentiment. It expires in 9 day(s) on November 1, 2024. Parties traded 110 contract(s) at a $50.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $34.1K, with a price of $310.0 per contract. There were 7451 open contracts at this strike prior to today, and today 310 contract(s) were bought and sold. 
• For GCT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>), we notice a call option trade that happens to be bearish, expiring in 86 day(s) on January 17, 2025. This event was a transfer of 88 contract(s) at a $25.00 strike. The total cost received by the writing party (or parties) was $28.1K, with a price of $320.0 per contract. There were 4863 open contracts at this strike prior to today, and today 237 contract(s) were bought and sold. 
• Regarding BLD (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLD#NYSE">BLD</a>), we observe a put option sweep with bullish sentiment. It expires in 23 day(s) on November 15, 2024. Parties traded 26 contract(s) at a $370.00 strike. This particular put needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $50.4K, with a price of $1940.0 per contract. There were 10 open contracts at this strike prior to today, and today 237 contract(s) were bought and sold. 
• Regarding WGO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>), we observe a put option trade with bullish sentiment. It expires in 86 day(s) on January 17, 2025. Parties traded 30 contract(s) at a $60.00 strike. The total cost received by the writing party (or parties) was $26.7K, with a price of $890.0 per contract. There were 2361 open contracts at this strike prior to today, and today 211 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

BABA

10 Consumer Discretionary Stocks Whale Activity In Today's Session

RBC Capital analyst Walter Spracklin reiterates Canadian National Railway (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CNR#TSX">CNR</a>) with a Outperform and maintains C$179 price target.

Reiteration

TSX:CNR

RBC Capital Reiterates Outperform on Canadian National Railway, Maintains C$179 Price Target

Asana Earnings: Don't Buy This Dip, Again

Asana sinks following latest earnings as multiple firms lower price targets

In a report released today, Patrick Walravens from JMP Securities maintained a Buy rating on Asana (ASAN – Research Report), with a price target of...

JMP Securities Reaffirms Their Buy Rating on Asana (ASAN)

Asana: Challenges Reflected In Bargain Share Price, But Sales Momentum Is Slowing (Rating Downgrade)

Smartsheet's Buyout Will Likely Improve Your Workflow Returns

Catalyst Watch: Earnings blitz, Fed speakers, and notable healthcare conferences

In a report released today, Josh Baer from Morgan Stanley maintained a Hold rating on Asana (ASAN – Research Report), with a price target of $14.00...

Cautious Hold Rating on Asana Amid AI Innovations and Market Uncertainties

The TipRanks All-star Analyst of the Day title goes to analyst Alex Zukin of Wolfe Research. Remarkably, Zukin ranks #70 out of the 9,147 Wall Stre...

TipRanks' All-Star Analyst – Who is the Best on MSFT Stock?

DA Davidson raised the firm's price target on Asana (ASAN) to $13 from $11 and keeps a Neutral rating on the shares. The company's Work Innovation ...

Asana price target raised to $13 from $11 at DA Davidson

D.A. Davidson analyst Lucky Schreiner maintained a Hold rating on Asana (ASAN – Research Report) today and set a price target of $13.00. The compan...

Asana (ASAN) Gets a Hold from D.A. Davidson

ALTM

AXNX

BIOX

BYON

CALM

CAMRF

DENN

ETON

FFIE

LOGI

MEDP

MNDY

MSFT

QCOM

RIVN

SMAR

TEAM

TMUS

UBER

WHLR

Press Releases

Asana Announces $150 Million Stock Repurchase Program

Asana to Announce Second Quarter Fiscal Year 2025 Financial Results on Tuesday, September 3, 2024

Asana Announces Fiscal 2024 ESG Report

Asana Announces Commitment to Pursuing FedRAMP Authorization

Asana Announces Second Quarter Fiscal 2025 Results

Asana Appoints Seasoned Finance Executive, Sonalee Parekh, as New Chief Financial Officer

Haymaker Group Expands Into San Francisco and Silicon Valley Markets, Building on A Decade of Impact Connecting Press with Tech Innovators and Investors

Asana Named a Leader in the 2024 Gartner® Magic Quadrant™ for Adaptive Project Management and Reporting

Asana Appoints Josh Abdulla as Head of Customer Experience

Asana Announces AI Studio: No-Code Builder for Designing and Deploying AI Agents in Critical Workflows

Comments

Asana

Asana (ASAN) Opciones

Asana (NYSE:ASAN) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL